Exosomal circKIF20B regulated the miR-615-3p/MEF2A axis to inhibit gefitinib resistance and NSCLC proliferation by arresting the cell cycle, promoting apoptosis, and reducing mitochondrial OXPHOS. Here, MEF2A is linked to non-small cell lung carcinoma.